# Divi's Laboratories Ltd. (Unit II) - Inspection Records

Source: https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf

> Inspection records and compliance data for Divi's Laboratories Ltd. (Unit II) in Visakhapatnam District, None. Access full analysis and detailed observations.

---

## Details

- Name: Divi's Laboratories Ltd. (Unit II)
- FEI Number: 3004149463
- City: Visakhapatnam District
- State: None
- Country Name: India
- Address Line 1: Chippada Village, Annavaram, Bheemunipatnam Mandal
- Zip Code: None
- Facility Type: API manufacturer
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - Divi's Laboratories Ltd. (Unit II) - 2024-07-19](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/c752310d-e2c0-48fa-af91-1e0c7248a11c) — source: FDA, date: July 19, 2024
- [FDA Inspection 1244994 - Divi's Laboratories Ltd. (Unit II) - 2024-07-19](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/4fa9eda6-d47f-4277-9097-87557d9fa978) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2024
- [FDA Inspection 1121124 - Divi's Laboratories Ltd. (Unit II) - 2020-01-31](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/6b800144-f691-4edd-97e9-5beb22fae64b) — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2020
- [483 - Divi's Laboratories Ltd. (Unit II) - 2017-09-19](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/85a9b4a5-0956-4d81-8d9f-f4a55c288d6b) — source: FDA, date: September 19, 2017
- [FDA Inspection 1029997 - Divi's Laboratories Ltd. (Unit II) - 2017-09-19](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/8de2af83-6a2e-41db-85f2-4ba57b235649) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2017
- [483 - Divi's Laboratories Ltd. (Unit II) - 2016-12-06](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/23cae6f9-b800-4f8d-8dd8-6ba18bdd4665) — source: FDA, date: December 6, 2016
- [FDA Inspection 996506 - Divi's Laboratories Ltd. (Unit II) - 2016-12-06](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/527a19bd-80f8-4b24-ab51-0d4ab07cf2d1) — classification: Official Action Indicated (OAI), source: FDA, date: December 6, 2016
- [FDA Inspection 960638 - Divi's Laboratories Ltd. (Unit II) - 2016-02-19](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/6bf61353-62c7-47fc-b52f-08fc035d420f) — classification: No Action Indicated (NAI), source: FDA, date: February 19, 2016
- [FDA Inspection 888915 - Divi's Laboratories Ltd. (Unit II) - 2014-06-06](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/725436c3-3a38-45c8-a2b0-67694d51a393) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2014
- [FDA Inspection 793556 - Divi's Laboratories Ltd. (Unit II) - 2012-07-19](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/ac133a3f-1151-41a4-8dce-5a4de0b4c20c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2012
- [FDA Inspection 577781 - Divi's Laboratories Ltd. (Unit II) - 2009-04-09](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/43a65072-0e5d-40ca-8840-702bb7b4b57e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2009

## Related Companies

- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Cambrex Profarmaco Milano Srl](https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb)
- [Sumitomo Chemical Co., Ltd.](https://www.keypedia.com/companies/sumitomo-chemical-co-ltd/3ce10d51-6999-467f-ac0e-cb6696a98aa5)
- [Eisai Co., Ltd. Kashima Plant](https://www.keypedia.com/companies/eisai-co-ltd-kashima-plant/70a3ccaf-c591-4ebf-952a-a2ee6a62e53c)
- [Pfizer Asia Manufacturing Pte Ltd.](https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Matrix Pharmacorp Private Limited](https://www.keypedia.com/companies/matrix-pharmacorp-private-limited/3cbdd9ae-291e-406d-9e2c-5479410bf998)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/b3bdc4a2-a966-484a-9ac4-f4715912e6e2)
- [Teva API India Private Ltd.](https://www.keypedia.com/companies/teva-api-india-private-ltd/aeeb5a05-7558-44f6-a08a-bb2f3d1aa3de)

## Related Officers

- [Consumer Safety Officer at Commissioned Corps of the U.S. Public Health Service](https://www.keypedia.com/people/latorie-s-jones/086d0897-7d63-4fa8-bdce-f1d17885abd7)
- [Biologist at CBER](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)
- [Compliance Officer / Investigator](https://www.keypedia.com/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)
- [Regulatory Affairs Specialist](https://www.keypedia.com/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)